# Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)

Source: https://welltoldgrants.com/grants/pa-23-189-research-supplements-to-promote-diversity-in-health-related/  
Official notice: https://www.grants.gov/search-results-detail/348963

> National Institutes of Health offered grants of up to $500,000 to small businesses. Applications closed on February 21, 2025.

| Field | Value |
|---|---|
| Opportunity number | PA-23-189 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | February 21, 2025 |
| Award ceiling | $500,000 |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.103 |

## Who can apply

- Small businesses

Other Eligible Applicants include the following:Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the HHS Grants Policy Statement, are not allowed. See full Notice of Funding Opportunity for additional details on Eligibility.

## What the grant funds

The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention hereby notify Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) holding specific types of research grants (activity codes listed above) that funds are available for administrative supplements to enhance the diversity of the research workforce by recruiting and supporting students, postdoctorates, and eligible investigators from diverse backgrounds, including those from groups that have been shown to be underrepresented in health-related research. This supplement opportunity is also available to PD(s)/PI(s) of research grants who are or become disabled and need additional support to accommodate their disability in order to continue to work on the research project. Administrative supplements must support work within the scope of the original project. This Notice of Funding Opportunity (NOFO) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial. Applicants to this NOFO are permitted to propose research experience in a clinical trial led by a mentor or co-mentor.

## Questions people ask

### Is PA-23-189 still open?

No. It closed on February 21, 2025.

### Who can apply for Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)?

National Institutes of Health accepted applications from small businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)?

Closed February 21, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $500,000 each.

### Who has been funded under PA-23-189?

NIH RePORTER lists 1,010 projects funded under PA-23-189 in fiscal 2023 to 2026, at 240 institutions. The most were at University of California, San Francisco, Stanford University, University of California at Davis.

### Who has won Food and Drug Administration Research grants before?

The largest recipients over five fiscal years were The Critical Path Institute, National Environmental Health Association, Association of Food & Drug Officials. The program made 940 awards worth $1.2 billion in that time.